Cargando…

Patient Knowledge and Attitudes towards Genetic Testing in Parkinson's Disease Subjects with Deep Brain Stimulation

OBJECTIVES: As genetic testing is becoming more widely commercially available for Parkinson's disease (PD) and may have implications regarding clinical outcomes for deep brain stimulation (DBS) and other therapies, we aimed to determine patient knowledge and attitudes towards genetic testing. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fraint, Avram, Ouyang, Bichun, Metman, Leonard Verhagen, Jones, Carolyn, Hall, Deborah A., Marder, Karen, Pal, Gian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501170/ https://www.ncbi.nlm.nih.gov/pubmed/31143438 http://dx.doi.org/10.1155/2019/3494609

Ejemplares similares

A Novel Dual-Frequency Deep Brain Stimulation Paradigm for Parkinson’s Disease
por: Karl, Jessica A., et al.
Publicado: (2019)

Long-Term Satisfaction and Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease
por: Karl, Jessica A., et al.
Publicado: (2018)

Deep Brain Stimulation in Tourette’s Syndrome
por: Fraint, Avram, et al.
Publicado: (2015)

Long-Term Clinical Experience with Directional Deep Brain Stimulation Programming: A Retrospective Review
por: Karl, Jessica A., et al.
Publicado: (2022)

Borders of STN determined by MRI versus the electrophysiological STN. A comparison using intraoperative CT
por: Bus, Sander, et al.
Publicado: (2017)

Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson Disease with Prior Pallidotomy or Thalamotomy
por: Khabarova, Elena A., et al.
Publicado: (2018)

Encoding type, medication, and deep brain stimulation differentially affect memory-guided sequential reaching movements in Parkinson's disease
por: David, Fabian J., et al.
Publicado: (2022)

The Effects of Subthalamic Nucleus Deep Brain Stimulation and Retention Delay on Memory-Guided Reaching Performance in People with Parkinson’s Disease
por: Trevarrow, Michael P., et al.
Publicado: (2023)

Acute Stroke in Middle Cerebellar Peduncle in a Patient With FXTAS
por: Hall, Deborah A., et al.
Publicado: (2018)

Improvement of Advanced Parkinson’s Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience
por: Rabie, Ahmed, et al.
Publicado: (2016)

Medication only improves limb movements while deep brain stimulation improves eye and limb movements during visually-guided reaching in Parkinson’s disease
por: Munoz, Miranda J., et al.
Publicado: (2023)

Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor
por: Robertson, Erin E., et al.
Publicado: (2020)

Knowledge, Attitude, and Perceptions about Deep Brain Stimulation for Parkinson’s Disease: Observations from a Single Indian Center
por: Prasad, Shweta, et al.
Publicado: (2021)

A Case Report of Myoclonus-Dystonia with Isolated Myoclonus Phenotype and Novel Mutation Successfully Treated with Deep Brain Stimulation
por: Besa Lehmann, Valentina, et al.
Publicado: (2020)

Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson disease
por: Pal, Gian D., et al.
Publicado: (2015)

High dose amantadine therapy may cause increased falling in patients with Parkinson's disease: A case report
por: Dames, Bridget, et al.
Publicado: (2020)

New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype
por: Fraint, Avram, et al.
Publicado: (2014)

Vocal Responses to Perturbations in Voice Auditory Feedback in Individuals with Parkinson's Disease
por: Liu, Hanjun, et al.
Publicado: (2012)

Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
por: Fraint, Avram, et al.
Publicado: (2016)

Medication adversely impacts visually-guided eye movements in Parkinson’s disease
por: Munoz, Miranda J., et al.
Publicado: (2022)

Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson’s disease
por: Gera, Anjali, et al.
Publicado: (2020)

Attenuated Postprandial GLP-1 Response in Parkinson’s Disease
por: Manfready, Richard A., et al.
Publicado: (2021)

Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson’s Disease in the United States
por: Amjad, Fahd, et al.
Publicado: (2019)

Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists
por: Alcalay, Roy N., et al.
Publicado: (2019)

Correction: Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists
por: Alcalay, Roy N., et al.
Publicado: (2019)

Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study
por: David, Fabian J., et al.
Publicado: (2021)

Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis
por: Artusi, Carlo Alberto, et al.
Publicado: (2019)

Gut microbial metabolites in Parkinson’s disease: Association with lifestyle, disease characteristics, and treatment status
por: Voigt, Robin M., et al.
Publicado: (2022)

Deep brain stimulation with a pre-existing cochlear implant: Surgical technique and outcome
por: Eddelman, Daniel, et al.
Publicado: (2017)

Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis
por: LeWitt, Peter A., et al.
Publicado: (2018)

Deep brain stimulation in Parkinson’s disease
por: Mehanna, Raja, et al.
Publicado: (2013)

Deep Brain Stimulation in Parkinson's Disease
por: Mehanna, Raja, et al.
Publicado: (2018)

Deep brain stimulation for Parkinson's disease
por: Hariz, Marwan, et al.
Publicado: (2022)

Subjective estimates of uncertainty during gambling and impulsivity after subthalamic deep brain stimulation for Parkinson’s disease
por: Paliwal, Saee, et al.
Publicado: (2019)

Expanding the spectrum of KCNJ6‐related disorders: Milder phenotype with pathological startle responses
por: van Midden, Vesna Marija, et al.
Publicado: (2022)

Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit
por: Merola, Aristide, et al.
Publicado: (2020)

Using “Functional” Target Coordinates of the Subthalamic Nucleus to Assess the Indirect and Direct Methods of the Preoperative Planning: Do the Anatomical and Functional Targets Coincide?
por: Rabie, Ahmed, et al.
Publicado: (2016)

Update on deep brain stimulation in Parkinson’s disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2015)

Adaptive deep brain stimulation in Parkinson's disease
por: Beudel, M., et al.
Publicado: (2016)

Deep Brain Stimulation in the Treatment of Parkinson’s Disease
por: Shah, Heeya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_klacnmkgm0h2rb0dv9ocinkdk0